Stock Price
1,409.85
Daily Change
-11.45 -0.81%
Monthly
8.18%
Yearly
16.55%
Q2 Forecast
1,382.70

Aurobindo Pharma reported INR82.63B in Debt for its fiscal quarter ending in March of 2025.





Debt Change Date
Cipla INR 4.38B 231.9M Mar/2025
Divis Laboratories Ltd INR 40M 40M Mar/2025
Dr.Reddys Laboratories INR 67.73B 9.19B Dec/2025
Hindustan Unilever INR 16.48B 30M Mar/2025
Sun Pharmaceuticals INR 23.62B 2.1B Mar/2025
UPL INR 250.99B 81.18B Mar/2025